News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
425,253 Results
Type
Article (33851)
Company Profile (170)
Press Release (391222)
Multimedia
Podcasts (53)
Webinars (19)
Section
Business (115077)
Career Advice (1621)
Deals (19463)
Drug Delivery (102)
Drug Development (51483)
Employer Resources (177)
FDA (10135)
Job Trends (10081)
News (198603)
Policy (17697)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2334)
Academic (2)
Accelerated approval (20)
Adcomms (21)
Allergies (128)
Alliances (31713)
ALS (130)
Alzheimer's disease (1222)
Antibody-drug conjugate (ADC) (170)
Approvals (10387)
Artificial intelligence (383)
Autoimmune disease (106)
Automation (32)
Bankruptcy (139)
Best Places to Work (8369)
BIOSECURE Act (14)
Biosimilars (135)
Biotechnology (94)
Bladder cancer (125)
Brain cancer (38)
Breast cancer (430)
Cancer (3055)
Cardiovascular disease (311)
Career advice (1428)
Career pathing (39)
CAR-T (202)
CDC (39)
Celiac Disease (1)
Cell therapy (529)
Cervical cancer (25)
Clinical research (44714)
Collaboration (1217)
Company closure (1)
Compensation (467)
Complete response letters (34)
COVID-19 (1926)
CRISPR (70)
C-suite (680)
Cystic fibrosis (120)
Data (4592)
Decentralized trials (1)
Denatured (29)
Depression (98)
Diabetes (380)
Diagnostics (4347)
Digital health (30)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (181)
Drug pricing (119)
Drug shortages (22)
Duchenne muscular dystrophy (166)
Earnings (37496)
Editorial (41)
Employer branding (24)
Employer resources (155)
Events (62576)
Executive appointments (781)
FDA (12404)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (10)
Funding (1099)
Gene editing (145)
Generative AI (33)
Gene therapy (463)
GLP-1 (693)
Government (2991)
Grass and pollen (4)
Guidances (271)
Healthcare (12384)
HIV (48)
Huntington's disease (30)
IgA nephropathy (69)
Immunology and inflammation (152)
Immuno-oncology (31)
Indications (68)
Infectious disease (2114)
Inflammatory bowel disease (157)
Inflation Reduction Act (12)
Influenza (78)
Intellectual property (136)
Interviews (259)
IPO (8401)
IRA (38)
Job creations (1991)
Job search strategy (1225)
JPM (37)
Kidney cancer (5)
Labor market (83)
Layoffs (280)
Leadership (31)
Legal (3271)
Liver cancer (61)
Longevity (13)
Lung cancer (378)
Lymphoma (269)
Machine learning (30)
Management (59)
Manufacturing (530)
MASH (116)
Medical device (8040)
Medtech (8079)
Mergers & acquisitions (11811)
Metabolic disorders (884)
Multiple sclerosis (120)
NASH (20)
Neurodegenerative disease (217)
Neuropsychiatric disorders (47)
Neuroscience (2129)
Neurotech (1)
NextGen: Class of 2026 (4612)
Non-profit (3993)
Now hiring (66)
Obesity (383)
Opinion (200)
Ovarian cancer (109)
Pain (145)
Pancreatic cancer (130)
Parkinson's disease (229)
Partnered (31)
Patents (227)
Patient recruitment (329)
Peanut (53)
People (41598)
Pharmaceutical (43)
Pharmacy benefit managers (17)
Phase 1 (12449)
Phase 2 (19561)
Phase 3 (16334)
Pipeline (3537)
Policy (189)
Postmarket research (1738)
Preclinical (5202)
Press Release (63)
Prostate cancer (173)
Psychedelics (34)
Radiopharmaceuticals (169)
Rare diseases (657)
Real estate (3889)
Recruiting (71)
Regulatory (14462)
Reports (49)
Research institute (2070)
Resumes & cover letters (205)
Rett syndrome (25)
RNA editing (11)
RSV (65)
Schizophrenia (108)
Series A (194)
Series B (134)
Service/supplier (8)
Sickle cell disease (73)
Special edition (14)
Spinal muscular atrophy (123)
Sponsored (32)
Startups (2781)
State (1)
Stomach cancer (11)
Supply chain (70)
Tariffs (32)
The Weekly (24)
Vaccines (696)
Venture capital (73)
Weight loss (246)
Women's health (57)
Worklife (21)
Date
Today (88)
Last 7 days (420)
Last 30 days (1376)
Last 365 days (19975)
2026 (2157)
2025 (20242)
2024 (23192)
2023 (26229)
2022 (33013)
2021 (36617)
2020 (34475)
2019 (31184)
2018 (23443)
2017 (20763)
2016 (20050)
2015 (22848)
2014 (16405)
2013 (13285)
2012 (14098)
2011 (14895)
2010 (13480)
Location
Africa (615)
Alabama (54)
Alaska (7)
Arizona (171)
Arkansas (10)
Asia (26226)
Australia (4684)
California (7039)
Canada (1959)
China (722)
Colorado (304)
Connecticut (311)
Delaware (269)
Europe (64626)
Florida (1132)
Georgia (255)
Hawaii (3)
Idaho (31)
Illinois (532)
India (59)
Indiana (477)
Iowa (20)
Japan (370)
Kansas (85)
Kentucky (31)
Louisiana (19)
Maine (26)
Maryland (873)
Massachusetts (5310)
Michigan (205)
Minnesota (406)
Mississippi (6)
Missouri (74)
Montana (22)
Nebraska (16)
Nevada (80)
New Hampshire (26)
New Jersey (2165)
New Mexico (21)
New York (2028)
North Carolina (1043)
North Dakota (9)
Northern California (3405)
Ohio (233)
Oklahoma (12)
Oregon (29)
Pennsylvania (1410)
Puerto Rico (14)
Rhode Island (27)
South America (810)
South Carolina (22)
Southern California (2730)
Tennessee (102)
Texas (975)
United States (25883)
Utah (182)
Vermont (1)
Virginia (160)
Washington D.C. (55)
Washington State (537)
West Virginia (2)
Wisconsin (97)
Wyoming (2)
425,253 Results for "sellas life sciences group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
January 15, 2026
·
5 min read
Press Releases
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
October 28, 2025
·
4 min read
Press Releases
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
December 29, 2025
·
5 min read
Press Releases
SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
·
10 min read
Press Releases
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
September 12, 2025
·
4 min read
Press Releases
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
December 8, 2025
·
5 min read
Press Releases
SSI Diagnostica Group strengthens life science portfolio for vaccine development and quality control with acquisition of US-based multiplexing company
February 4, 2026
·
1 min read
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Press Releases
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update
October 1, 2025
·
5 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q4 2025
BioSpace’s 2025 Q4 U.S. Life Sciences Job Market update highlights early signs of stabilization in biopharma hiring, with modest gains in job postings, slowing layoffs, and cautiously improving sentiment heading into 2026.
January 19, 2026
·
1 min read
·
BioSpace Insights
1 of 42,526
Next
